These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9434158)

  • 21. Eukaryotic topoisomerase II cleavage is independent of duplex DNA conformation.
    Choi IY; Chung IK; Muller MT
    Biochim Biophys Acta; 1995 Nov; 1264(2):209-14. PubMed ID: 7495865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.
    Takano H; Kohno K; Ono M; Uchida Y; Kuwano M
    Cancer Res; 1991 Aug; 51(15):3951-7. PubMed ID: 1649696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tirapazamine: a hypoxia-activated topoisomerase II poison.
    Peters KB; Brown JM
    Cancer Res; 2002 Sep; 62(18):5248-53. PubMed ID: 12234992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide.
    DeVore RF; Corbett AH; Osheroff N
    Cancer Res; 1992 Apr; 52(8):2156-61. PubMed ID: 1313738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topoisomerase Assays.
    Nitiss JL; Kiianitsa K; Sun Y; Nitiss KC; Maizels N
    Curr Protoc; 2021 Oct; 1(10):e250. PubMed ID: 34606690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics.
    Käs E; Laemmli UK
    EMBO J; 1992 Feb; 11(2):705-16. PubMed ID: 1311255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events.
    Sørensen BS; Sinding J; Andersen AH; Alsner J; Jensen PB; Westergaard O
    J Mol Biol; 1992 Dec; 228(3):778-86. PubMed ID: 1335085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes.
    Burden DA; Kingma PS; Froelich-Ammon SJ; Bjornsti MA; Patchan MW; Thompson RB; Osheroff N
    J Biol Chem; 1996 Nov; 271(46):29238-44. PubMed ID: 8910583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
    Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
    Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Base excision repair intermediates as topoisomerase II poisons.
    Wilstermann AM; Osheroff N
    J Biol Chem; 2001 Dec; 276(49):46290-6. PubMed ID: 11591703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoposide, topoisomerase II and cancer.
    Baldwin EL; Osheroff N
    Curr Med Chem Anticancer Agents; 2005 Jul; 5(4):363-72. PubMed ID: 16101488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iridoids as DNA topoisomerase I poisons.
    Gálvez M; Martín-Cordero C; Ayuso MJ
    J Enzyme Inhib Med Chem; 2005 Aug; 20(4):389-92. PubMed ID: 16206835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
    Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM
    Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thioguanine substitution alters DNA cleavage mediated by topoisomerase II.
    Krynetskaia NF; Cai X; Nitiss JL; Krynetski EY; Relling MV
    FASEB J; 2000 Nov; 14(14):2339-44. PubMed ID: 11053256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons.
    Kingma PS; Corbett AH; Burcham PC; Marnett LJ; Osheroff N
    J Biol Chem; 1995 Sep; 270(37):21441-4. PubMed ID: 7665552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,4-Benzoquinone is a topoisomerase II poison.
    Lindsey RH; Bromberg KD; Felix CA; Osheroff N
    Biochemistry; 2004 Jun; 43(23):7563-74. PubMed ID: 15182198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using 3'-bridging phosphorothiolates to isolate the forward DNA cleavage reaction of human topoisomerase IIalpha.
    Deweese JE; Burgin AB; Osheroff N
    Biochemistry; 2008 Apr; 47(13):4129-40. PubMed ID: 18318502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topoisomerase-II-mediated DNA cleavage within the human ribosomal genes.
    Govoni M; Neri S; Labella T; Sylvester JE; Novello F; Pession A
    Biochem Biophys Res Commun; 1995 Aug; 213(1):282-8. PubMed ID: 7639746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.